<DOC>
	<DOC>NCT01495715</DOC>
	<brief_summary>The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.</brief_summary>
	<brief_title>Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)</brief_title>
	<detailed_description />
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Atrophy, Hereditary, Leber</mesh_term>
	<mesh_term>Idebenone</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Age &gt; or equal 10 years and &lt; 65 years Impaired visual acuity in affected eyes due to LHON: Visual acuity in best eye &gt;0.4 logMAR No explanation for visual loss besides LHON Any previous use of idebenone Participation in another clinical trial of any investigational drug within 3 months prior to Baseline Previous participation in Study SNTII003 (RHODOS) for idebenone.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>